nodes	percent_of_prediction	percent_of_DWPC	metapath
Dapiprazole—Risperidone—ABCB1—ulcerative colitis	0.0189	1	CrCbGaD
Dapiprazole—ADRA1B—Monoamine GPCRs—ADRB2—ulcerative colitis	0.0175	0.0179	CbGpPWpGaD
Dapiprazole—ADRA1B—LPA receptor mediated events—GNA12—ulcerative colitis	0.0174	0.0177	CbGpPWpGaD
Dapiprazole—ADRA1A—GPCRs, Class A Rhodopsin-like—GPR35—ulcerative colitis	0.0171	0.0174	CbGpPWpGaD
Dapiprazole—ADRA1A—Monoamine GPCRs—ADRB2—ulcerative colitis	0.0156	0.0159	CbGpPWpGaD
Dapiprazole—ADRA1B—G alpha (12/13) signalling events—GNA12—ulcerative colitis	0.0153	0.0156	CbGpPWpGaD
Dapiprazole—ADRA1D—GPCRs, Other—CXCR2—ulcerative colitis	0.015	0.0152	CbGpPWpGaD
Dapiprazole—ADRA1B—Amine ligand-binding receptors—ADRB2—ulcerative colitis	0.0147	0.015	CbGpPWpGaD
Dapiprazole—ADRA1B—AMPK Signaling—HNF4A—ulcerative colitis	0.0142	0.0144	CbGpPWpGaD
Dapiprazole—ADRA1A—G alpha (12/13) signalling events—GNA12—ulcerative colitis	0.0136	0.0138	CbGpPWpGaD
Dapiprazole—ADRA1A—Amine ligand-binding receptors—ADRB2—ulcerative colitis	0.0131	0.0133	CbGpPWpGaD
Dapiprazole—ADRA1A—AMPK Signaling—HNF4A—ulcerative colitis	0.0126	0.0128	CbGpPWpGaD
Dapiprazole—ADRA1D—GPCRs, Other—ADRB2—ulcerative colitis	0.00939	0.00957	CbGpPWpGaD
Dapiprazole—ADRA1B—LPA receptor mediated events—ADCY5—ulcerative colitis	0.00876	0.00893	CbGpPWpGaD
Dapiprazole—ADRA1D—GPCRs, Class A Rhodopsin-like—CXCR1—ulcerative colitis	0.00831	0.00847	CbGpPWpGaD
Dapiprazole—ADRA1D—Calcium Regulation in the Cardiac Cell—CALM3—ulcerative colitis	0.0074	0.00754	CbGpPWpGaD
Dapiprazole—ADRA1D—Class A/1 (Rhodopsin-like receptors)—CXCR1—ulcerative colitis	0.00712	0.00725	CbGpPWpGaD
Dapiprazole—ADRA1B—GPCRs, Class A Rhodopsin-like—CXCR1—ulcerative colitis	0.00689	0.00703	CbGpPWpGaD
Dapiprazole—ADRA1D—GPCRs, Class A Rhodopsin-like—CXCR2—ulcerative colitis	0.0065	0.00662	CbGpPWpGaD
Dapiprazole—ADRA1D—G alpha (q) signalling events—GHRL—ulcerative colitis	0.00637	0.0065	CbGpPWpGaD
Dapiprazole—ADRA1D—Calcium Regulation in the Cardiac Cell—ADRB2—ulcerative colitis	0.00633	0.00645	CbGpPWpGaD
Dapiprazole—ADRA1D—Class A/1 (Rhodopsin-like receptors)—CCL20—ulcerative colitis	0.00625	0.00637	CbGpPWpGaD
Dapiprazole—ADRA1B—Calcium Regulation in the Cardiac Cell—CALM3—ulcerative colitis	0.00614	0.00626	CbGpPWpGaD
Dapiprazole—ADRA1A—GPCRs, Class A Rhodopsin-like—CXCR1—ulcerative colitis	0.00612	0.00624	CbGpPWpGaD
Dapiprazole—ADRA1D—GPCRs, Class A Rhodopsin-like—CCR6—ulcerative colitis	0.00611	0.00623	CbGpPWpGaD
Dapiprazole—ADRA1B—Class A/1 (Rhodopsin-like receptors)—CXCR1—ulcerative colitis	0.00591	0.00602	CbGpPWpGaD
Dapiprazole—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—GHRL—ulcerative colitis	0.0057	0.00581	CbGpPWpGaD
Dapiprazole—ADRA1D—Class A/1 (Rhodopsin-like receptors)—CXCR2—ulcerative colitis	0.00557	0.00568	CbGpPWpGaD
Dapiprazole—ADRA1A—Calcium Regulation in the Cardiac Cell—CALM3—ulcerative colitis	0.00546	0.00556	CbGpPWpGaD
Dapiprazole—ADRA1D—GPCR ligand binding—CXCR1—ulcerative colitis	0.00542	0.00552	CbGpPWpGaD
Dapiprazole—ADRA1B—GPCRs, Class A Rhodopsin-like—CXCR2—ulcerative colitis	0.00539	0.0055	CbGpPWpGaD
Dapiprazole—ADRA1D—GPCRs, Class A Rhodopsin-like—PTGER4—ulcerative colitis	0.00538	0.00548	CbGpPWpGaD
Dapiprazole—ADRA1D—Calcium Regulation in the Cardiac Cell—ADCY5—ulcerative colitis	0.00537	0.00547	CbGpPWpGaD
Dapiprazole—ADRA1B—LPA receptor mediated events—RELA—ulcerative colitis	0.00529	0.00539	CbGpPWpGaD
Dapiprazole—ADRA1B—G alpha (q) signalling events—GHRL—ulcerative colitis	0.00529	0.00539	CbGpPWpGaD
Dapiprazole—ADRA1B—Calcium Regulation in the Cardiac Cell—ADRB2—ulcerative colitis	0.00525	0.00535	CbGpPWpGaD
Dapiprazole—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CXCR1—ulcerative colitis	0.00525	0.00535	CbGpPWpGaD
Dapiprazole—ADRA1D—Class A/1 (Rhodopsin-like receptors)—CCR6—ulcerative colitis	0.00524	0.00534	CbGpPWpGaD
Dapiprazole—ADRA1B—Class A/1 (Rhodopsin-like receptors)—CCL20—ulcerative colitis	0.00519	0.00529	CbGpPWpGaD
Dapiprazole—ADRA1B—GPCRs, Class A Rhodopsin-like—CCR6—ulcerative colitis	0.00507	0.00517	CbGpPWpGaD
Dapiprazole—ADRA1B—LPA receptor mediated events—CXCL8—ulcerative colitis	0.00499	0.00508	CbGpPWpGaD
Dapiprazole—ADRA1A—GPCRs, Class A Rhodopsin-like—CXCR2—ulcerative colitis	0.00479	0.00488	CbGpPWpGaD
Dapiprazole—ADRA1D—GPCR ligand binding—CCL20—ulcerative colitis	0.00476	0.00485	CbGpPWpGaD
Dapiprazole—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—GHRL—ulcerative colitis	0.00473	0.00482	CbGpPWpGaD
Dapiprazole—ADRA1A—G alpha (q) signalling events—GHRL—ulcerative colitis	0.0047	0.00479	CbGpPWpGaD
Dapiprazole—ADRA1A—Calcium Regulation in the Cardiac Cell—ADRB2—ulcerative colitis	0.00466	0.00475	CbGpPWpGaD
Dapiprazole—ADRA1B—Class A/1 (Rhodopsin-like receptors)—CXCR2—ulcerative colitis	0.00462	0.00471	CbGpPWpGaD
Dapiprazole—ADRA1D—Class A/1 (Rhodopsin-like receptors)—PTGER4—ulcerative colitis	0.00461	0.0047	CbGpPWpGaD
Dapiprazole—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CCL20—ulcerative colitis	0.00461	0.00469	CbGpPWpGaD
Dapiprazole—ADRA1B—LPA receptor mediated events—MMP9—ulcerative colitis	0.00451	0.0046	CbGpPWpGaD
Dapiprazole—ADRA1A—GPCRs, Class A Rhodopsin-like—CCR6—ulcerative colitis	0.00451	0.00459	CbGpPWpGaD
Dapiprazole—ADRA1B—GPCR ligand binding—CXCR1—ulcerative colitis	0.0045	0.00458	CbGpPWpGaD
Dapiprazole—ADRA1B—GPCRs, Class A Rhodopsin-like—PTGER4—ulcerative colitis	0.00447	0.00455	CbGpPWpGaD
Dapiprazole—ADRA1B—LPA receptor mediated events—NFKB1—ulcerative colitis	0.00446	0.00455	CbGpPWpGaD
Dapiprazole—ADRA1B—Calcium Regulation in the Cardiac Cell—ADCY5—ulcerative colitis	0.00446	0.00454	CbGpPWpGaD
Dapiprazole—ADRA1B—Class A/1 (Rhodopsin-like receptors)—CCR6—ulcerative colitis	0.00435	0.00443	CbGpPWpGaD
Dapiprazole—ADRA1D—GPCR ligand binding—CXCR2—ulcerative colitis	0.00424	0.00432	CbGpPWpGaD
Dapiprazole—ADRA1D—Class A/1 (Rhodopsin-like receptors)—GHRL—ulcerative colitis	0.00422	0.0043	CbGpPWpGaD
Dapiprazole—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—GHRL—ulcerative colitis	0.0042	0.00428	CbGpPWpGaD
Dapiprazole—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CXCR2—ulcerative colitis	0.00411	0.00418	CbGpPWpGaD
Dapiprazole—ADRA1D—GPCRs, Class A Rhodopsin-like—ADRB2—ulcerative colitis	0.00408	0.00416	CbGpPWpGaD
Dapiprazole—ADRA1A—GPCR ligand binding—CXCR1—ulcerative colitis	0.004	0.00407	CbGpPWpGaD
Dapiprazole—ADRA1D—GPCR ligand binding—CCR6—ulcerative colitis	0.00399	0.00406	CbGpPWpGaD
Dapiprazole—ADRA1A—GPCRs, Class A Rhodopsin-like—PTGER4—ulcerative colitis	0.00397	0.00404	CbGpPWpGaD
Dapiprazole—ADRA1A—Calcium Regulation in the Cardiac Cell—ADCY5—ulcerative colitis	0.00396	0.00403	CbGpPWpGaD
Dapiprazole—ADRA1B—GPCR ligand binding—CCL20—ulcerative colitis	0.00395	0.00402	CbGpPWpGaD
Dapiprazole—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CCR6—ulcerative colitis	0.00386	0.00393	CbGpPWpGaD
Dapiprazole—ADRA1B—Class A/1 (Rhodopsin-like receptors)—PTGER4—ulcerative colitis	0.00383	0.0039	CbGpPWpGaD
Dapiprazole—ADRA1B—GPCR ligand binding—CXCR2—ulcerative colitis	0.00352	0.00359	CbGpPWpGaD
Dapiprazole—ADRA1D—GPCR ligand binding—PTGER4—ulcerative colitis	0.00351	0.00358	CbGpPWpGaD
Dapiprazole—ADRA1A—GPCR ligand binding—CCL20—ulcerative colitis	0.00351	0.00358	CbGpPWpGaD
Dapiprazole—ADRA1B—Class A/1 (Rhodopsin-like receptors)—GHRL—ulcerative colitis	0.0035	0.00357	CbGpPWpGaD
Dapiprazole—ADRA1D—Class A/1 (Rhodopsin-like receptors)—ADRB2—ulcerative colitis	0.00349	0.00356	CbGpPWpGaD
Dapiprazole—ADRA1A—Class A/1 (Rhodopsin-like receptors)—PTGER4—ulcerative colitis	0.0034	0.00346	CbGpPWpGaD
Dapiprazole—ADRA1B—GPCRs, Class A Rhodopsin-like—ADRB2—ulcerative colitis	0.00338	0.00345	CbGpPWpGaD
Dapiprazole—ADRA1B—GPCR ligand binding—CCR6—ulcerative colitis	0.00331	0.00337	CbGpPWpGaD
Dapiprazole—ADRA1D—GPCR ligand binding—GHRL—ulcerative colitis	0.00321	0.00328	CbGpPWpGaD
Dapiprazole—ADRA1A—GPCR ligand binding—CXCR2—ulcerative colitis	0.00313	0.00319	CbGpPWpGaD
Dapiprazole—ADRA1A—Class A/1 (Rhodopsin-like receptors)—GHRL—ulcerative colitis	0.00311	0.00317	CbGpPWpGaD
Dapiprazole—ADRA1D—GPCR downstream signaling—CXCR1—ulcerative colitis	0.00306	0.00312	CbGpPWpGaD
Dapiprazole—ADRA1A—GPCRs, Class A Rhodopsin-like—ADRB2—ulcerative colitis	0.00301	0.00306	CbGpPWpGaD
Dapiprazole—ADRA1A—GPCR ligand binding—CCR6—ulcerative colitis	0.00294	0.003	CbGpPWpGaD
Dapiprazole—ADRA1B—GPCR ligand binding—PTGER4—ulcerative colitis	0.00291	0.00297	CbGpPWpGaD
Dapiprazole—ADRA1B—Class A/1 (Rhodopsin-like receptors)—ADRB2—ulcerative colitis	0.0029	0.00296	CbGpPWpGaD
Dapiprazole—ADRA1B—AMPK Signaling—TP53—ulcerative colitis	0.00288	0.00294	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling by GPCR—CXCR1—ulcerative colitis	0.00278	0.00283	CbGpPWpGaD
Dapiprazole—ADRA1D—GPCR downstream signaling—CCL20—ulcerative colitis	0.00269	0.00274	CbGpPWpGaD
Dapiprazole—ADRA1B—GPCR ligand binding—GHRL—ulcerative colitis	0.00267	0.00272	CbGpPWpGaD
Dapiprazole—ADRA1D—GPCR ligand binding—ADRB2—ulcerative colitis	0.00266	0.00271	CbGpPWpGaD
Dapiprazole—ADRA1A—GPCR ligand binding—PTGER4—ulcerative colitis	0.00259	0.00264	CbGpPWpGaD
Dapiprazole—ADRA1A—Class A/1 (Rhodopsin-like receptors)—ADRB2—ulcerative colitis	0.00258	0.00263	CbGpPWpGaD
Dapiprazole—ADRA1A—AMPK Signaling—TP53—ulcerative colitis	0.00256	0.00261	CbGpPWpGaD
Dapiprazole—ADRA1B—GPCR downstream signaling—CXCR1—ulcerative colitis	0.00254	0.00259	CbGpPWpGaD
Dapiprazole—ADRA1D—GPCR downstream signaling—GNA12—ulcerative colitis	0.00253	0.00258	CbGpPWpGaD
Dapiprazole—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—JAK2—ulcerative colitis	0.0025	0.00254	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling by GPCR—CCL20—ulcerative colitis	0.00244	0.00249	CbGpPWpGaD
Dapiprazole—ADRA1D—GPCR downstream signaling—CXCR2—ulcerative colitis	0.0024	0.00244	CbGpPWpGaD
Dapiprazole—ADRA1A—GPCR ligand binding—GHRL—ulcerative colitis	0.00237	0.00241	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling by GPCR—CXCR1—ulcerative colitis	0.00231	0.00235	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling by GPCR—GNA12—ulcerative colitis	0.0023	0.00234	CbGpPWpGaD
Dapiprazole—ADRA1A—GPCR downstream signaling—CXCR1—ulcerative colitis	0.00226	0.0023	CbGpPWpGaD
Dapiprazole—ADRA1D—GPCR downstream signaling—CCR6—ulcerative colitis	0.00225	0.0023	CbGpPWpGaD
Dapiprazole—ADRA1B—GPCR downstream signaling—CCL20—ulcerative colitis	0.00223	0.00227	CbGpPWpGaD
Dapiprazole—ADRA1B—GPCR ligand binding—ADRB2—ulcerative colitis	0.00221	0.00225	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling by GPCR—CXCR2—ulcerative colitis	0.00218	0.00222	CbGpPWpGaD
Dapiprazole—ADRA1B—GPCR downstream signaling—GNA12—ulcerative colitis	0.0021	0.00214	CbGpPWpGaD
Dapiprazole—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—JAK2—ulcerative colitis	0.00207	0.00211	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling by GPCR—CXCR1—ulcerative colitis	0.00205	0.00209	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling by GPCR—CCR6—ulcerative colitis	0.00205	0.00209	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling by GPCR—CCL20—ulcerative colitis	0.00203	0.00207	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—SEL1L—ulcerative colitis	0.002	0.00203	CbGpPWpGaD
Dapiprazole—ADRA1B—GPCR downstream signaling—CXCR2—ulcerative colitis	0.00199	0.00203	CbGpPWpGaD
Dapiprazole—ADRA1D—GPCR downstream signaling—PTGER4—ulcerative colitis	0.00198	0.00202	CbGpPWpGaD
Dapiprazole—ADRA1A—GPCR downstream signaling—CCL20—ulcerative colitis	0.00198	0.00202	CbGpPWpGaD
Dapiprazole—ADRA1A—GPCR ligand binding—ADRB2—ulcerative colitis	0.00196	0.002	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling by GPCR—GNA12—ulcerative colitis	0.00191	0.00194	CbGpPWpGaD
Dapiprazole—ADRA1B—GPCR downstream signaling—CCR6—ulcerative colitis	0.00187	0.00191	CbGpPWpGaD
Dapiprazole—ADRA1A—GPCR downstream signaling—GNA12—ulcerative colitis	0.00186	0.0019	CbGpPWpGaD
Dapiprazole—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—JAK2—ulcerative colitis	0.00184	0.00188	CbGpPWpGaD
Dapiprazole—ADRA1D—GPCR downstream signaling—GHRL—ulcerative colitis	0.00182	0.00185	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling by GPCR—CXCR2—ulcerative colitis	0.00181	0.00184	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling by GPCR—PTGER4—ulcerative colitis	0.0018	0.00184	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling by GPCR—CCL20—ulcerative colitis	0.0018	0.00183	CbGpPWpGaD
Dapiprazole—ADRA1A—GPCR downstream signaling—CXCR2—ulcerative colitis	0.00177	0.0018	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling by GPCR—CCR6—ulcerative colitis	0.0017	0.00173	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling by GPCR—GNA12—ulcerative colitis	0.00169	0.00173	CbGpPWpGaD
Dapiprazole—ADRA1D—Class A/1 (Rhodopsin-like receptors)—CXCL8—ulcerative colitis	0.00169	0.00172	CbGpPWpGaD
Dapiprazole—ADRA1A—GPCR downstream signaling—CCR6—ulcerative colitis	0.00166	0.00169	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—SEL1L—ulcerative colitis	0.00166	0.00169	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling by GPCR—GHRL—ulcerative colitis	0.00165	0.00168	CbGpPWpGaD
Dapiprazole—ADRA1B—GPCR downstream signaling—PTGER4—ulcerative colitis	0.00165	0.00168	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—CXCR1—ulcerative colitis	0.00164	0.00167	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling by GPCR—CXCR2—ulcerative colitis	0.0016	0.00164	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling by GPCR—CALM3—ulcerative colitis	0.0016	0.00163	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling by GPCR—CCR6—ulcerative colitis	0.00151	0.00154	CbGpPWpGaD
Dapiprazole—ADRA1B—GPCR downstream signaling—GHRL—ulcerative colitis	0.00151	0.00154	CbGpPWpGaD
Dapiprazole—ADRA1D—GPCR downstream signaling—ADRB2—ulcerative colitis	0.0015	0.00153	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling by GPCR—PTGER4—ulcerative colitis	0.0015	0.00152	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—SEL1L—ulcerative colitis	0.00147	0.0015	CbGpPWpGaD
Dapiprazole—ADRA1A—GPCR downstream signaling—PTGER4—ulcerative colitis	0.00146	0.00149	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—CCL20—ulcerative colitis	0.00144	0.00147	CbGpPWpGaD
Dapiprazole—ADRA1B—Class A/1 (Rhodopsin-like receptors)—CXCL8—ulcerative colitis	0.0014	0.00143	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling by GPCR—GHRL—ulcerative colitis	0.00137	0.0014	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling by GPCR—ADRB2—ulcerative colitis	0.00137	0.00139	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—CXCR1—ulcerative colitis	0.00136	0.00139	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—GNA12—ulcerative colitis	0.00136	0.00138	CbGpPWpGaD
Dapiprazole—ADRA1A—GPCR downstream signaling—GHRL—ulcerative colitis	0.00134	0.00136	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling by GPCR—PTGER4—ulcerative colitis	0.00133	0.00135	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling by GPCR—CALM3—ulcerative colitis	0.00133	0.00135	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—CXCR2—ulcerative colitis	0.00129	0.00131	CbGpPWpGaD
Dapiprazole—ADRA1D—GPCR ligand binding—CXCL8—ulcerative colitis	0.00128	0.00131	CbGpPWpGaD
Dapiprazole—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—ulcerative colitis	0.00128	0.0013	CbGpPWpGaD
Dapiprazole—ADRA1D—GPCR downstream signaling—ADCY5—ulcerative colitis	0.00128	0.0013	CbGpPWpGaD
Dapiprazole—ADRA1B—GPCR downstream signaling—ADRB2—ulcerative colitis	0.00125	0.00127	CbGpPWpGaD
Dapiprazole—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CXCL8—ulcerative colitis	0.00124	0.00127	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling by GPCR—GHRL—ulcerative colitis	0.00122	0.00124	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—CXCR1—ulcerative colitis	0.00121	0.00123	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—CCR6—ulcerative colitis	0.00121	0.00123	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—CCL20—ulcerative colitis	0.0012	0.00122	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling by GPCR—CALM3—ulcerative colitis	0.00118	0.0012	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling by GPCR—ADCY5—ulcerative colitis	0.00116	0.00118	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—MAML2—ulcerative colitis	0.00115	0.00117	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling by GPCR—ADRB2—ulcerative colitis	0.00113	0.00115	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—GNA12—ulcerative colitis	0.00113	0.00115	CbGpPWpGaD
Dapiprazole—ADRA1A—GPCR downstream signaling—ADRB2—ulcerative colitis	0.00111	0.00113	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—CXCR2—ulcerative colitis	0.00107	0.00109	CbGpPWpGaD
Dapiprazole—ADRA1B—GPCR ligand binding—CXCL8—ulcerative colitis	0.00107	0.00109	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—PTGER4—ulcerative colitis	0.00106	0.00108	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—CCL20—ulcerative colitis	0.00106	0.00108	CbGpPWpGaD
Dapiprazole—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—ulcerative colitis	0.00106	0.00108	CbGpPWpGaD
Dapiprazole—ADRA1B—GPCR downstream signaling—ADCY5—ulcerative colitis	0.00106	0.00108	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling by GPCR—ADRB2—ulcerative colitis	0.00101	0.00103	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—CCR6—ulcerative colitis	0.001	0.00102	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—GNA12—ulcerative colitis	0.001	0.00102	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—GHRL—ulcerative colitis	0.000974	0.000993	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling by GPCR—ADCY5—ulcerative colitis	0.000962	0.00098	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—MAML2—ulcerative colitis	0.000951	0.000969	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—CXCR2—ulcerative colitis	0.000948	0.000966	CbGpPWpGaD
Dapiprazole—ADRA1A—GPCR ligand binding—CXCL8—ulcerative colitis	0.000947	0.000965	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—CALM3—ulcerative colitis	0.000944	0.000962	CbGpPWpGaD
Dapiprazole—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—ulcerative colitis	0.000944	0.000962	CbGpPWpGaD
Dapiprazole—ADRA1A—GPCR downstream signaling—ADCY5—ulcerative colitis	0.000941	0.000959	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—RIPK2—ulcerative colitis	0.000929	0.000947	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—CCR6—ulcerative colitis	0.000891	0.000908	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—PTGER4—ulcerative colitis	0.000883	0.0009	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling by GPCR—ADCY5—ulcerative colitis	0.000854	0.000871	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—MAML2—ulcerative colitis	0.000845	0.000861	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—GHRL—ulcerative colitis	0.000809	0.000824	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—ADRB2—ulcerative colitis	0.000806	0.000822	CbGpPWpGaD
Dapiprazole—ADRA1D—GPCR downstream signaling—JAK2—ulcerative colitis	0.000796	0.000811	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—PTGER4—ulcerative colitis	0.000785	0.0008	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—CALM3—ulcerative colitis	0.000783	0.000798	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—RIPK2—ulcerative colitis	0.000771	0.000786	CbGpPWpGaD
Dapiprazole—ADRA1D—GPCR downstream signaling—CXCL8—ulcerative colitis	0.000726	0.00074	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling by GPCR—JAK2—ulcerative colitis	0.000722	0.000736	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—GHRL—ulcerative colitis	0.000718	0.000732	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—CALM3—ulcerative colitis	0.000696	0.000709	CbGpPWpGaD
Dapiprazole—ADRA1D—GPCR downstream signaling—IL2—ulcerative colitis	0.000694	0.000707	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—RIPK2—ulcerative colitis	0.000685	0.000698	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—ADCY5—ulcerative colitis	0.000685	0.000698	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—ADRB2—ulcerative colitis	0.000669	0.000682	CbGpPWpGaD
Dapiprazole—ADRA1B—GPCR downstream signaling—JAK2—ulcerative colitis	0.00066	0.000673	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling by GPCR—CXCL8—ulcerative colitis	0.000659	0.000672	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling by GPCR—IL2—ulcerative colitis	0.00063	0.000642	CbGpPWpGaD
Dapiprazole—ADRA1B—GPCR downstream signaling—CXCL8—ulcerative colitis	0.000603	0.000614	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling by GPCR—JAK2—ulcerative colitis	0.0006	0.000611	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—ADRB2—ulcerative colitis	0.000595	0.000606	CbGpPWpGaD
Dapiprazole—ADRA1A—GPCR downstream signaling—JAK2—ulcerative colitis	0.000586	0.000598	CbGpPWpGaD
Dapiprazole—ADRA1B—GPCR downstream signaling—IL2—ulcerative colitis	0.000576	0.000587	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—ADCY5—ulcerative colitis	0.000568	0.000579	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling by GPCR—CXCL8—ulcerative colitis	0.000547	0.000558	CbGpPWpGaD
Dapiprazole—ADRA1A—GPCR downstream signaling—CXCL8—ulcerative colitis	0.000535	0.000546	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling by GPCR—JAK2—ulcerative colitis	0.000533	0.000543	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling by GPCR—IL2—ulcerative colitis	0.000523	0.000533	CbGpPWpGaD
Dapiprazole—ADRA1A—GPCR downstream signaling—IL2—ulcerative colitis	0.000512	0.000521	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—ADCY5—ulcerative colitis	0.000505	0.000514	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling by GPCR—CXCL8—ulcerative colitis	0.000486	0.000495	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling by GPCR—IL2—ulcerative colitis	0.000465	0.000473	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—JAK2—ulcerative colitis	0.000427	0.000435	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—RELA—ulcerative colitis	0.000413	0.000421	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—CXCL8—ulcerative colitis	0.000389	0.000397	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—IL2—ulcerative colitis	0.000372	0.000379	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling by GPCR—IL6—ulcerative colitis	0.00037	0.000378	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—JAK2—ulcerative colitis	0.000354	0.000361	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—MMP9—ulcerative colitis	0.000352	0.000359	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—NFKB1—ulcerative colitis	0.000349	0.000355	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—RELA—ulcerative colitis	0.000343	0.00035	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—CXCL8—ulcerative colitis	0.000323	0.00033	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—JAK2—ulcerative colitis	0.000315	0.000321	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—STAT3—ulcerative colitis	0.000313	0.000319	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—IL2—ulcerative colitis	0.000309	0.000315	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling by GPCR—IL6—ulcerative colitis	0.000307	0.000313	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—RELA—ulcerative colitis	0.000305	0.000311	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—MMP9—ulcerative colitis	0.000292	0.000298	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—TGFB1—ulcerative colitis	0.00029	0.000296	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—NFKB1—ulcerative colitis	0.000289	0.000295	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—CXCL8—ulcerative colitis	0.000287	0.000293	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—IL2—ulcerative colitis	0.000274	0.00028	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling by GPCR—IL6—ulcerative colitis	0.000273	0.000278	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—STAT3—ulcerative colitis	0.00026	0.000265	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—MMP9—ulcerative colitis	0.00026	0.000265	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—NFKB1—ulcerative colitis	0.000257	0.000262	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—TGFB1—ulcerative colitis	0.000241	0.000246	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—TP53—ulcerative colitis	0.000239	0.000244	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—STAT3—ulcerative colitis	0.000231	0.000235	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—IL6—ulcerative colitis	0.000219	0.000223	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—TGFB1—ulcerative colitis	0.000214	0.000218	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—TP53—ulcerative colitis	0.000198	0.000202	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—IL6—ulcerative colitis	0.000182	0.000185	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—TP53—ulcerative colitis	0.000176	0.00018	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—IL6—ulcerative colitis	0.000161	0.000164	CbGpPWpGaD
